Breaking News Instant updates and real-time market news.

2020-11-14 04:55:00 ADAP Adaptimmune $4.98 / +0.18 (+3.75%) , ALKS Alkermes $17.77 / +0.45 (+2.60%) … 04:55 11/14/20 11/14 04:55 11/14/20 04:55	Society for Immunotherapy of Cancer to hold virtual annual meeting SITC Virtual Annual Meeting 2020 will be held on November 9-14. Webcast Link ADAP Adaptimmune $4.98 / +0.18 (+3.75%) ALKS Alkermes $17.77 / +0.45 (+2.60%) ALXO ALX Oncology $51.40 / -0.7 (-1.34%) AZN AstraZeneca $57.37 / +0.54 (+0.95%) BAYRY Bayer $0.00 / + (+0.00%) BMY Bristol-Myers $63.63 / +0.88 (+1.40%) CRVS Corvus Pharmaceuticals $4.11 / +0.01 (+0.24%) EXEL Exelixis $20.15 / -0.08 (-0.40%) IMAB I-MAB $37.07 / +2.75 (+8.01%) INCY Incyte $82.53 / +0.24 (+0.29%) IOVA Iovance Biotherapeutics $37.72 / +0.91 (+2.47%) NKTR Nektar $17.27 / +0.13 (+0.76%) NSTG NanoString $46.23 / -0.54 (-1.15%) NVS Novartis $86.09 / +0.475 (+0.55%) PFE Pfizer $38.64 / +1.085 (+2.89%) REGN Regeneron $566.54 / +8.43 (+1.51%) TRIL Trillium Therapeutics $15.50 / +1.44 (+10.24%) VAR Varian Medical $173.79 / +0.31 (+0.18%)	15 Nov 16 Nov 18 Nov 23 Nov 05 Dec 15 Dec 15 Dec 24 Jan 11 Feb 20 Feb 27 Mar 17 Jan 22 Jan 23 Jan 27 May 29 May 02 Jun 17 Jul 11 Sep 08 Oct
ADAP ALKS ALXO AZN BAYRY BMY CRVS EXEL IMAB INCY IOVA NKTR NSTG NVS PFE REGN TRIL VAR ADAP Adaptimmune $4.98 / +0.18 (+3.75%) 08/12/20 Piper Sandler TCR2 Therapeutics initiated with an Overweight at Piper Sandler 06/01/20 Mizuho Adaptimmune price target raised to $9 from $3 at Mizuho 05/29/20 JonesTrading JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern' 05/29/20 JonesTrading Adaptimmune upgraded to Buy from Hold at JonesTrading ALKS Alkermes $17.77 / +0.45 (+2.60%) 10/30/20 Gordon Haskett wonders if Alex Denner will 'ruffle any feathers' at Alkermes 10/30/20 Mizuho Alkermes risk/reward remains attractive after 'strong' Q3, says Mizuho 10/15/20 Mizuho Alkermes upgraded to Buy from Neutral at Mizuho 10/12/20 Cantor Fitzgerald Alkermes shares should react positively to Adcom vote, says Cantor Fitzgerald ALXO ALX Oncology $51.40 / -0.7 (-1.34%) 10/14/20 Piper Sandler ALX Oncology tumor data 'incrementally positive,' says Piper Sandler 10/05/20 Piper Sandler Patent fight likely to weigh on ALX Oncology shares NT, says Piper Sandler 09/18/20 Piper Sandler Piper Sandler lays out next potential takeover targets in oncology 08/27/20 Piper Sandler ALX Oncology on track for catalyst-rich 12 months, says Piper Sandler AZN AstraZeneca $57.37 / +0.54 (+0.95%) 11/11/20 Oppenheimer Amgen price target raised to $280 from $275 at Oppenheimer 11/11/20 HSBC AstraZeneca upgraded to Hold from Reduce at HSBC 11/11/20 HSBC AstraZeneca upgraded to Hold from Reduce at HSBC 10/23/20 Stifel FibroGen safety data mitigates concerns of roxadustat black box, says Stifel BAYRY Bayer $0.00 / + (+0.00%) 11/06/20 Morgan Stanley Bayer price target lowered to EUR 67 from EUR 68 at Morgan Stanley 11/05/20 Deutsche Bank Bayer price target lowered to EUR 62 from EUR 64 at Deutsche Bank 11/05/20 JPMorgan Bayer price target lowered to EUR 52 from EUR 77 at JPMorgan 11/04/20 Credit Suisse Bayer price target lowered to EUR 47 from EUR 50 at Credit Suisse BMY Bristol-Myers $63.63 / +0.88 (+1.40%) 11/10/20 Bernstein Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein 11/10/20 Bernstein Bristol-Myers initiated with a Market Perform at Bernstein 11/06/20 Gabelli Bristol-Myers downgraded to Hold from Buy at Gabelli 11/05/20 BofA BofA sees Bristol-Myers as $80 stock, 'no reason' for shares to be down CRVS Corvus Pharmaceuticals $4.11 / +0.01 (+0.24%) 10/05/20 Wedbush Corvus' COVID-19 program data supports further advancement, says Wedbush 09/14/20 Mizuho Oncology 'fertile ground for M&A activity,' says Mizuho 03/10/20 H.C. Wainwright Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright 12/09/19 Mizuho Corvus pipeline updates 'can only be additive,' says Mizuho EXEL Exelixis $20.15 / -0.08 (-0.40%) 10/26/20 Piper Sandler Exelixis could have successor to Cabometyx with XL092, says Piper Sandler 09/22/20 Morgan Stanley Exelixis price target raised to $29 from $23 at Morgan Stanley 09/21/20 Piper Sandler Exelixis price target raised to $33 from $30 at Piper Sandler 06/30/20 Piper Sandler Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler IMAB I-MAB $37.07 / +2.75 (+8.01%) 09/08/20 Cantor Fitzgerald I-MAB price target raised to $55 from $50 at Cantor Fitzgerald 07/27/20 Cantor Fitzgerald I-MAB initiated with an Overweight at Cantor Fitzgerald 02/14/20 Fly Intel: Top five analyst initiations 02/13/20 CICC I-MAB initiated with an Outperform at CICC INCY Incyte $82.53 / +0.24 (+0.29%) 11/06/20 RBC Capital Incyte price target lowered to $86 from $96 at RBC Capital 08/05/20 Mizuho Incyte price target raised to $95 from $79 at Mizuho IOVA Iovance Biotherapeutics $37.72 / +0.91 (+2.47%) 11/09/20 Piper Sandler Iovance data bode well for future combo readouts, says Piper Sandler 11/06/20 Barclays Iovance Biotherapeutics price target raised to $43 from $36 at Barclays 11/06/20 Piper Sandler Iovance Biotherapeutics price target raised to $45 from $35 at Piper Sandler 10/15/20 Wells Fargo Iovance Biotherapeutics price target raised to $35 from $29 at Wells Fargo NKTR Nektar $17.27 / +0.13 (+0.76%) 11/11/20 Piper Sandler Nektar reported 'validating' updates across its portfolio, says Piper Sandler 11/05/20 Piper Sandler Nektar's PROPEL lung update got more interesting, says Piper Sandler 10/27/20 Piper Sandler Piper Sandler cautious on Nektar's new COVID-19 trial 09/14/20 JPMorgan Nektar resumed with a Neutral at JPMorgan NSTG NanoString $46.23 / -0.54 (-1.15%) 09/09/20 Morgan Stanley Veracyte initiated with an Underweight at Morgan Stanley 09/09/20 Morgan Stanley NanoString initiated with an Equal Weight at Morgan Stanley 05/11/20 Baird NanoString price target raised to $34 from $29 at Baird 03/11/20 JPMorgan JPMorgan continues to recommend select exposure to Life Science Tools NVS Novartis $86.09 / +0.475 (+0.55%) 11/10/20 JPMorgan Novartis price target raised to CHF 85 from CHF 82 at JPMorgan 10/26/20 JMP Securities Kura Oncology price target raised to $33 from $22 at JMP Securities 09/29/20 Berenberg Novartis initiated with a Buy at Berenberg 09/24/20 Barclays Regenxbio price target lowered to $79 from $88 at Barclays PFE Pfizer $38.64 / +1.085 (+2.89%) 11/13/20 JPMorgan Pfizer shares reflect close to best case vaccine scenario, says JPMorgan 11/12/20 BofA Epam Systems upgraded to Buy from Neutral at BofA 11/12/20 B. Riley Securities Altimmune selloff on vaccine news overblown, says B. Riley Securities 11/11/20 BMO Capital Sonoco stands to benefit from COVID-19 vaccine progress, says BMO Capital REGN Regeneron $566.54 / +8.43 (+1.51%) 11/11/20 Truist Opthea initiated with a Buy at Truist 11/10/20 SVB Leerink Regeneron price target lowered to $643 from $653 at SVB Leerink 11/06/20 Truist Regeneron price target raised to $770 from $750 at Truist 11/05/20 Piper Sandler Regeneron shares will continue moving higher, says Piper Sandler TRIL Trillium Therapeutics $15.50 / +1.44 (+10.24%) 11/04/20 Cowen Trillium ASH abstracts provide 'minimal updates', says Cowen 10/12/20 Evercore ISI Trillium Therapeutics initiated with an Outperform at Evercore ISI 10/01/20 Cowen Trillium strengthens position with CD47 patent news, says Cowen VAR Varian Medical $173.79 / +0.31 (+0.18%) 10/28/20 Barrington Varian Medical downgraded to Underperform from Outperform at Barrington 10/28/20 Baird Varian Medical downgraded to Neutral at Baird 10/28/20 Baird Varian downgraded to Neutral from Outperform at Baird 10/07/20 Piper Sandler ViewRay amended agreement with Siemens favorable, says Piper Sandler

2020-11-14 04:55:00

ADAP

Adaptimmune

$4.98 / +0.18 (+3.75%)

, ALKS

Alkermes

$17.77 / +0.45 (+2.60%)

… 04:55

11/14/20

11/14

04:55

11/14/20

04:55

Society for Immunotherapy of Cancer to hold virtual annual meeting

SITC Virtual Annual Meeting 2020 will be held on November 9-14. Webcast Link

ADAP

Adaptimmune

$4.98 / +0.18 (+3.75%)

ALKS

Alkermes

$17.77 / +0.45 (+2.60%)

ALXO

ALX Oncology

$51.40 / -0.7 (-1.34%)

AZN

AstraZeneca

$57.37 / +0.54 (+0.95%)

BAYRY

Bayer

$0.00 / + (+0.00%)

BMY

Bristol-Myers

$63.63 / +0.88 (+1.40%)

CRVS

Corvus Pharmaceuticals

$4.11 / +0.01 (+0.24%)

EXEL

Exelixis

$20.15 / -0.08 (-0.40%)

IMAB

I-MAB

$37.07 / +2.75 (+8.01%)

INCY

Incyte

$82.53 / +0.24 (+0.29%)

IOVA

Iovance Biotherapeutics

$37.72 / +0.91 (+2.47%)

NKTR

Nektar

$17.27 / +0.13 (+0.76%)

NSTG

NanoString

$46.23 / -0.54 (-1.15%)

NVS

Novartis

$86.09 / +0.475 (+0.55%)

PFE

Pfizer

$38.64 / +1.085 (+2.89%)

REGN

Regeneron

$566.54 / +8.43 (+1.51%)

TRIL

Trillium Therapeutics

$15.50 / +1.44 (+10.24%)

VAR

Varian Medical

$173.79 / +0.31 (+0.18%)

15
Nov
16
Nov
18
Nov
23
Nov
05
Dec
15
Dec
15
Dec
24
Jan
11
Feb
20
Feb
27
Mar

17
Jan
22
Jan
23
Jan
27
May
29
May
02
Jun
17
Jul
11
Sep
08
Oct

ADAP
ALKS
ALXO
AZN
BAYRY
BMY
CRVS
EXEL
IMAB
INCY
IOVA
NKTR
NSTG
NVS
PFE
REGN
TRIL
VAR

ADAP Adaptimmune

$4.98 / +0.18 (+3.75%)

08/12/20 Piper Sandler: TCR2 Therapeutics initiated with an Overweight at Piper Sandler

06/01/20 Mizuho: Adaptimmune price target raised to $9 from $3 at Mizuho

05/29/20 JonesTrading: JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'

05/29/20 JonesTrading: Adaptimmune upgraded to Buy from Hold at JonesTrading

ALKS Alkermes

$17.77 / +0.45 (+2.60%)

10/30/20: Gordon Haskett wonders if Alex Denner will 'ruffle any feathers' at Alkermes

10/30/20 Mizuho: Alkermes risk/reward remains attractive after 'strong' Q3, says Mizuho

10/15/20 Mizuho: Alkermes upgraded to Buy from Neutral at Mizuho

10/12/20 Cantor Fitzgerald: Alkermes shares should react positively to Adcom vote, says Cantor Fitzgerald

ALXO ALX Oncology

$51.40 / -0.7 (-1.34%)

10/14/20 Piper Sandler: ALX Oncology tumor data 'incrementally positive,' says Piper Sandler

10/05/20 Piper Sandler: Patent fight likely to weigh on ALX Oncology shares NT, says Piper Sandler

09/18/20 Piper Sandler: Piper Sandler lays out next potential takeover targets in oncology

08/27/20 Piper Sandler: ALX Oncology on track for catalyst-rich 12 months, says Piper Sandler

AZN AstraZeneca

$57.37 / +0.54 (+0.95%)

11/11/20 Oppenheimer: Amgen price target raised to $280 from $275 at Oppenheimer

11/11/20 HSBC: AstraZeneca upgraded to Hold from Reduce at HSBC

11/11/20 HSBC: AstraZeneca upgraded to Hold from Reduce at HSBC

10/23/20 Stifel: FibroGen safety data mitigates concerns of roxadustat black box, says Stifel

BAYRY Bayer

$0.00 / + (+0.00%)

11/06/20 Morgan Stanley: Bayer price target lowered to EUR 67 from EUR 68 at Morgan Stanley

11/05/20 Deutsche Bank: Bayer price target lowered to EUR 62 from EUR 64 at Deutsche Bank

11/05/20 JPMorgan: Bayer price target lowered to EUR 52 from EUR 77 at JPMorgan

11/04/20 Credit Suisse: Bayer price target lowered to EUR 47 from EUR 50 at Credit Suisse

BMY Bristol-Myers

$63.63 / +0.88 (+1.40%)

11/10/20 Bernstein: Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein

11/10/20 Bernstein: Bristol-Myers initiated with a Market Perform at Bernstein

11/06/20 Gabelli: Bristol-Myers downgraded to Hold from Buy at Gabelli

11/05/20 BofA: BofA sees Bristol-Myers as $80 stock, 'no reason' for shares to be down

CRVS Corvus Pharmaceuticals

$4.11 / +0.01 (+0.24%)

10/05/20 Wedbush: Corvus' COVID-19 program data supports further advancement, says Wedbush

09/14/20 Mizuho: Oncology 'fertile ground for M&A activity,' says Mizuho

03/10/20 H.C. Wainwright: Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright

12/09/19 Mizuho: Corvus pipeline updates 'can only be additive,' says Mizuho

EXEL Exelixis

$20.15 / -0.08 (-0.40%)

10/26/20 Piper Sandler: Exelixis could have successor to Cabometyx with XL092, says Piper Sandler

09/22/20 Morgan Stanley: Exelixis price target raised to $29 from $23 at Morgan Stanley

09/21/20 Piper Sandler: Exelixis price target raised to $33 from $30 at Piper Sandler

06/30/20 Piper Sandler: Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler

IMAB I-MAB

$37.07 / +2.75 (+8.01%)

09/08/20 Cantor Fitzgerald: I-MAB price target raised to $55 from $50 at Cantor Fitzgerald

07/27/20 Cantor Fitzgerald: I-MAB initiated with an Overweight at Cantor Fitzgerald

02/14/20: Fly Intel: Top five analyst initiations

02/13/20 CICC: I-MAB initiated with an Outperform at CICC

INCY Incyte

$82.53 / +0.24 (+0.29%)

11/06/20 RBC Capital: Incyte price target lowered to $86 from $96 at RBC Capital

08/05/20 Mizuho: Incyte price target raised to $95 from $79 at Mizuho

IOVA Iovance Biotherapeutics

$37.72 / +0.91 (+2.47%)

11/09/20 Piper Sandler: Iovance data bode well for future combo readouts, says Piper Sandler

11/06/20 Barclays: Iovance Biotherapeutics price target raised to $43 from $36 at Barclays

11/06/20 Piper Sandler: Iovance Biotherapeutics price target raised to $45 from $35 at Piper Sandler

10/15/20 Wells Fargo: Iovance Biotherapeutics price target raised to $35 from $29 at Wells Fargo

NKTR Nektar

$17.27 / +0.13 (+0.76%)

11/11/20 Piper Sandler: Nektar reported 'validating' updates across its portfolio, says Piper Sandler

11/05/20 Piper Sandler: Nektar's PROPEL lung update got more interesting, says Piper Sandler

10/27/20 Piper Sandler: Piper Sandler cautious on Nektar's new COVID-19 trial

09/14/20 JPMorgan: Nektar resumed with a Neutral at JPMorgan

NSTG NanoString

$46.23 / -0.54 (-1.15%)

09/09/20 Morgan Stanley: Veracyte initiated with an Underweight at Morgan Stanley

09/09/20 Morgan Stanley: NanoString initiated with an Equal Weight at Morgan Stanley

05/11/20 Baird: NanoString price target raised to $34 from $29 at Baird

03/11/20 JPMorgan: JPMorgan continues to recommend select exposure to Life Science Tools

NVS Novartis

$86.09 / +0.475 (+0.55%)

11/10/20 JPMorgan: Novartis price target raised to CHF 85 from CHF 82 at JPMorgan

10/26/20 JMP Securities: Kura Oncology price target raised to $33 from $22 at JMP Securities

09/29/20 Berenberg: Novartis initiated with a Buy at Berenberg

09/24/20 Barclays: Regenxbio price target lowered to $79 from $88 at Barclays

PFE Pfizer

$38.64 / +1.085 (+2.89%)

11/13/20 JPMorgan: Pfizer shares reflect close to best case vaccine scenario, says JPMorgan

11/12/20 BofA: Epam Systems upgraded to Buy from Neutral at BofA

11/12/20 B. Riley Securities: Altimmune selloff on vaccine news overblown, says B. Riley Securities

11/11/20 BMO Capital: Sonoco stands to benefit from COVID-19 vaccine progress, says BMO Capital

REGN Regeneron

$566.54 / +8.43 (+1.51%)

11/11/20 Truist: Opthea initiated with a Buy at Truist

11/10/20 SVB Leerink: Regeneron price target lowered to $643 from $653 at SVB Leerink

11/06/20 Truist: Regeneron price target raised to $770 from $750 at Truist

11/05/20 Piper Sandler: Regeneron shares will continue moving higher, says Piper Sandler

TRIL Trillium Therapeutics

$15.50 / +1.44 (+10.24%)

11/04/20 Cowen: Trillium ASH abstracts provide 'minimal updates', says Cowen

10/12/20 Evercore ISI: Trillium Therapeutics initiated with an Outperform at Evercore ISI

10/01/20 Cowen: Trillium strengthens position with CD47 patent news, says Cowen

VAR Varian Medical

$173.79 / +0.31 (+0.18%)

10/28/20 Barrington: Varian Medical downgraded to Underperform from Outperform at Barrington

10/28/20 Baird: Varian Medical downgraded to Neutral at Baird

10/28/20 Baird: Varian downgraded to Neutral from Outperform at Baird

10/07/20 Piper Sandler: ViewRay amended agreement with Siemens favorable, says Piper Sandler

TODAY'S FREE FLY STORIES

Recommendations	Wajax price target raised to C$20 from C$18.50 at Raymond James » 12:27 03/03/21 03/03 12:27 03/03/21 12:27 WJXFF Wajax $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research WJXFF Wajax $0.00 / + (+0.00%) 11:30 Today Scotiabank Wajax price target raised to C$26 from C$25 at Scotiabank 11:14 Today TD Securities Wajax price target raised to C$24 from C$20 at TD Securities 01/25/21 Scotiabank Wajax upgraded to Outperform from Sector Perform at Scotiabank 01/07/21 TD Securities Wajax price target raised to C$20 from C$17.50 at TD Securities
Recommendations	Nuvista Energy price target raised to C$3 from C$2.50 at Raymond James » 12:26 03/03/21 03/03 12:26 03/03/21 12:26 NUVSF Nuvista Energy $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research NUVSF Nuvista Energy $0.00 / + (+0.00%) 11:12 Today TD Securities Nuvista Energy price target raised to C$2.50 from C$2 at TD Securities 02/26/21 Stifel Nuvista Energy price target raised to C$2.25 from C$1.50 at Stifel 02/26/21 BMO Capital Nuvista Energy price target raised to C$2.50 from C$1.25 at BMO Capital 02/26/21 CIBC Nuvista Energy price target raised to C$2.25 from C$1.25 at CIBC
Recommendations	Neo Performance price target raised to C$21 from C$18 at Raymond James » 12:25 03/03/21 03/03 12:25 03/03/21 12:25 NOPMF Neo Performance Materials $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NOPMF Neo Performance Materials $0.00 / + (+0.00%) 03/02/21 Energy Fuels, Neo Performance Materials announce joint venture launch NOPMF Neo Performance Materials $0.00 / + (+0.00%) 03/02/21 Scotiabank Neo Performance Materials price target raised to C$20 from C$17 at Scotiabank 03/02/21 Stifel Neo Performance Materials upgraded to Buy from Hold at Stifel 03/02/21 Stifel Neo Performance Materials upgraded to Buy from Hold at Stifel 02/18/21 Canaccord Neo Performance Materials price target raised to C$20 from C$16 at Canaccord
Recommendations	Conifex Timber price target raised to C$2.60 from C$2.50 at Raymond James » 12:25 03/03/21 03/03 12:25 03/03/21 12:25 CFXTF Conifex Timber $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CFXTF Conifex Timber $0.00 / + (+0.00%) 01/06/21 Conifex Timber CFO Jordan Neeser resigns 01/06/21 Conifex Timber working to resume operations at Mackenzie power plant CFXTF Conifex Timber $0.00 / + (+0.00%) 02/04/21 CIBC Conifex Timber price target raised to C$2.50 from C$2 at CIBC 01/13/21 Raymond James Conifex Timber price target raised to C$2.50 from C$2.25 at Raymond James 12/18/20 CIBC Conifex Timber price target raised to C$2 from C$1.60 at CIBC 12/10/20 Raymond James Conifex Timber price target raised to C$2.25 from C$1.75 at Raymond James
Options	Teck Resources call volume above normal and directionally bullish » 12:25 03/03/21 03/03 12:25 03/03/21 12:25 TECK Teck Resources $21.65 / +0.43 (+2.03%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options TECK Teck Resources $21.65 / +0.43 (+2.03%) 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 02/16/21 Teck Resources doubles water treatment capacity at Elkview operations 01/07/21 Teck Resources, Ktunaxa Nation sign joint management agreement 11/27/20 Teck Resources expands Copper and Health program to Chile TECK Teck Resources $21.65 / +0.43 (+2.03%) 03/01/21 CIBC Teck Resources price target raised to C$32 from C$25 at CIBC 02/19/21 TD Securities Teck Resources price target raised to C$34 from C$30 at TD Securities 02/19/21 RBC Capital Teck Resources price target lowered to C$32 from C$33 at RBC Capital 02/19/21 B. Riley Securities Teck Resources price target raised to C$33 from C$31 at B. Riley Securities TECK Teck Resources $21.65 / +0.43 (+2.03%) 02/18/21 Teck Resources reports Q4 adjusted EPS C$0.46 vs, C$0.40 last year 10/27/20 Teck Resources reports Q3 adj. EPS C$0.24 vs. C$0.69 last year 04/28/21 Teck Resources - TECK TECK Teck Resources $21.65 / +0.43 (+2.03%) 02/23/21 Teck Resources put volume heavy and directionally bearish 02/19/21 Teck Resources call volume above normal and directionally bullish 02/12/21 Teck Resources put volume heavy and directionally bearish 01/27/21 Teck Resources put volume heavy and directionally bearish

Conference/Events	CFA Society of Chicago to hold a virtual event » 12:25 03/03/21 03/03 12:25 03/03/21 12:25 Chicago Federal Reserve… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Velodyne Lidar management to meet virtually with Benchmark » 12:25 03/03/21 03/03 12:25 03/03/21 12:25 VLDR Velodyne Lidar $15.33 / -0.67 (-4.19%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VLDR Velodyne Lidar $15.33 / -0.67 (-4.19%) 02/22/21 Velodyne Lidar appoints Dr. Joseph Culkin chairman effective immediately 02/19/21 Luminar, Velodyne Lidar move up after Bloomberg says Apple looking at LiDAR 02/10/21 Velodyne Lidar signs five-year sales agreement with ThorDrive 01/26/21 Velodyne Lidar signs multi-year sales agreement with Emesent VLDR Velodyne Lidar $15.33 / -0.67 (-4.19%) 02/09/21 Craig-Hallum Velodyne target cut to $29 at Craig-Hallum as 'lower visibility' reasons emerge 01/14/21 Fly Intel: Top five analyst initiations 01/14/21 Benchmark Benchmark starts 'first mover' Velodyne Lidar at Buy with $32 price target 01/14/21 Benchmark Velodyne Lidar initiated with a Buy at Benchmark VLDR Velodyne Lidar $15.33 / -0.67 (-4.19%) 02/25/21 Velodyne Lidar reports Q4 EPS (12c), consensus (11c) 01/07/21 Velodyne Lidar sees Q4 revenue $15.5M-$16M, consensus $29.55M VLDR Velodyne Lidar $15.33 / -0.67 (-4.19%) 02/19/21 Apple in talks with LiDAR suppliers for self-driving car project, Bloomberg says 12/15/20 Mobileye CEO sees building own LIDAR sensors to control costs, Reuters says 12/08/20 Citron pans 'suckers game' Luminar, prefers Velodyne Lidar shares 12/08/20 Velodyne Lidar shares will rally to $30, Citron Research says VLDR Velodyne Lidar $15.33 / -0.67 (-4.19%) 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 13:00 Today Velodyne Lidar VLDR Velodyne Lidar $15.33 / -0.67 (-4.19%) 03/01/21 Velodyne Lidar call volume above normal and directionally bullish 02/25/21 Velodyne Lidar options imply 21.0% move in share price post-earnings 01/26/21 Velodyne Lidar call volume above normal and directionally bullish 12/30/20 Velodyne Lidar call volume above normal and directionally bullish
On The Fly	Fly Intel: Wall Street's top stories at midday » 12:24 03/03/21 03/03 12:24 03/03/21 12:24 DLTR Dollar Tree $104.04 / +5 (+5.05%) , JWN Nordstrom $35.58 / -1.87 (-4.99%) , MIK Michaels $22.18 / +4.15 (+23.02%) , APO Apollo Global $50.95 / +1.06 (+2.12%) , LVS Las Vegas Sands $66.12 / +1.18 (+1.82%) , VICI VICI Properties $28.88 / +0.25 (+0.87%) , GM General Motors $53.83 / -0.29 (-0.54%) , SSNLF Samsung $0.00 / + (+0.00%) , OVID Ovid Therapeutics $4.01 / +1.055 (+35.70%) , TAK Takeda Pharmaceutical $17.55 / +0.3 (+1.74%) , LYFT Lyft $62.05 / +4.99 (+8.75%) , VIR Vir Biotechnology $39.75 / -18.05 (-31.23%) , WEN Wendy's $20.25 / -1.05 (-4.93%) The major averages are… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options DLTR JWN MIK APO LVS VICI GM SSNLF OVID TAK LYFT VIR WEN DLTR Dollar Tree $104.04 / +5 (+5.05%) 07:38 Today Dollar Tree sees FY21 store openings of 600 02/16/21 SPAR Group appoints Mike Matacunas as president, CEO 02/04/21 Instacart announces new national delivery partnership with Family Dollar 12/07/20 Dollar Tree CEO sells 12.4K shares of common stock JWN Nordstrom $35.58 / -1.87 (-4.99%) 03/02/21 Nordstrom says overall trends improved sequentially throughout the quarter 03/02/21 Nordstrom says taking actions to 'significantly reduce inventory levels' in Q1 03/02/21 Nordstrom says Q4 digital sales of about $2B represented 54% of business 03/01/21 Nordstrom, Tonal form partnership MIK Michaels $22.18 / +4.15 (+23.02%) 09:50 Today Michaels trading resumes 09:19 Today Apollo Global to acquire Michaels for $22.00 per share in cash 09:14 Today Michaels trading halted, news pending 03/01/21 Michaels jumps 10% after NY Times report of private equity interest APO Apollo Global $50.95 / +1.06 (+2.12%) 09:19 Today Apollo Global to acquire Michaels for $22.00 per share in cash 06:38 Today VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B 06:34 Today Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B 06:34 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B LVS Las Vegas Sands $66.12 / +1.18 (+1.82%) 06:38 Today VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B 06:34 Today Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B 06:34 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B 03/01/21 Macau reports February casino revenue up 135.6% to 7.31B patacas VICI VICI Properties $28.88 / +0.25 (+0.87%) 06:38 Today VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B 06:34 Today Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B 06:34 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B 12/24/20 VICI Properties enters triple-net lease agreement with EBCI GM General Motors $53.83 / -0.29 (-0.54%) 11:52 Today General Motors extends plant shutdowns due to semiconductor shortage 02/25/21 Caterpillar elects Gerald Johnson to board of directors 02/17/21 EU passenger car registrations down 24.0% in January 02/16/21 Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4 SSNLF Samsung $0.00 / + (+0.00%) 03/02/21 ITC to investigate certain cellular devices made by Samsung, Motorola Mobility 02/19/21 Solas OLED announces patent dispute settlement with LG Display 01/27/21 Samsung sees Memory business recovering during H1 01/17/21 Fly Intel: Top five weekend stock stories OVID Ovid Therapeutics $4.01 / +1.055 (+35.70%) 08:27 Today Takeda secures rights to soticlestat from Ovid Therapeutics for $196M upfront 12/16/20 Ovid Therapeutics announces addition to Nasdaq Biotechnology Index 12/01/20 Ovid Therapeutics falls 43% to $3.75 after failed ph.3 trial of OV101 12/01/20 Ovid Therapeutics ph.3 NEPTUNE trial of OV101 does not meet primary endpoint TAK Takeda Pharmaceutical $17.55 / +0.3 (+1.74%) 08:27 Today Takeda secures rights to soticlestat from Ovid Therapeutics for $196M upfront 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/26/21 Takeda to divest type 2 diabetes portfolio to Teijin Pharma for JPY 133B 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan LYFT Lyft $62.05 / +4.99 (+8.75%) 03/02/21 Lyft raises Q1 adjusted EBITDA view to ($135M) from ($150M)-($145M) 02/10/21 GM not planning to partner with rideshare players as EV portfolio rolls out 02/09/21 Lyft jumps 5% to $56.50 per share after Q4 results 02/09/21 Lyft reports Q4 active riders 12,552, down 45.2% VIR Vir Biotechnology $39.75 / -18.05 (-31.23%) 09:08 Today Vir, GSK: DSMB recommends VIR-7831 arm of ACTIV-3 trial be closed to enrollment 02/17/21 GlaxoSmithKline, Vir expand coronavirus collaboration for respiratory viruses 02/01/21 Vir Biotechnology announces publication on SARS-CoV-2 spike protein 01/27/21 Vir Biotechnology trading resumes WEN Wendy's $20.25 / -1.05 (-4.93%) 07:09 Today Wendy's says Q1 sales 'off to a strong start' 07:08 Today Wendy's sees FY21 cash flows from operations: $310M-$330M 07:05 Today Wendy's reports Q4 global same-restaurant sales growth 4.7% 07:03 Today Wendy's reports Q4 U.S. systemwide sales growth of 14.2% DLTR JWN MIK APO LVS VICI GM SSNLF OVID TAK LYFT VIR WEN DLTR Dollar Tree $104.04 / +5 (+5.05%) 02/25/21 Fly Intel: Pre-market Movers 02/25/21 BofA BofA double downgrades Dollar Tree to Underperform, sees multiple headwinds 02/25/21 BofA Dollar Tree downgraded to Underperform from Buy at BofA 02/16/21 JPMorgan Dollar Tree price target raised to $134 from $130 at JPMorgan JWN Nordstrom $35.58 / -1.87 (-4.99%) 02/16/21 JPMorgan Nordstrom price target raised to $40 from $34 at JPMorgan 02/10/21 Gordon Haskett Nordstrom upgraded to Buy from Hold at Gordon Haskett 01/21/21 Deutsche Bank Nordstrom price target raised to $43 from $24 at Deutsche Bank 01/14/21 Credit Suisse Nordstrom price target raised to $39 from $26 at Credit Suisse MIK Michaels $22.18 / +4.15 (+23.02%) 01/20/21 Morgan Stanley Morgan Stanley downgrades Michaels to Underweight, sees 'too much optimism' 01/20/21 Morgan Stanley Michaels downgraded to Underweight from Equal Weight at Morgan Stanley 12/14/20 JPMorgan Michaels downgraded to Neutral after recent rally at JPMorgan 12/14/20 JPMorgan Michaels downgraded to Neutral from Overweight at JPMorgan APO Apollo Global $50.95 / +1.06 (+2.12%) 10:02 Today Stifel Las Vegas Sands casino sale news 'clearly a positive,' says Stifel 01/20/21 Truist Athene Holding price target raised to $55 from $48 at Truist 01/11/21 Wells Fargo Apollo Global price target raised to $55 from $50 at Wells Fargo 12/18/20 Deutsche Bank Apollo Global price target raised to $51 from $49 at Deutsche Bank LVS Las Vegas Sands $66.12 / +1.18 (+1.82%) 12:03 Today Roth Capital Golden Entertainment shares worth $40 based on Sands deal, says Roth Capital 10:02 Today Stifel Las Vegas Sands casino sale news 'clearly a positive,' says Stifel 02/09/21 Morgan Stanley Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds 02/08/21 Fly Intel: Top five analyst downgrades VICI VICI Properties $28.88 / +0.25 (+0.87%) 10:02 Today Stifel Las Vegas Sands casino sale news 'clearly a positive,' says Stifel 02/22/21 Deutsche Bank VICI Properties price target raised to $32 from $28 at Deutsche Bank 01/26/21 Goldman Sachs VICI Properties price target raised to $33 from $27 at Goldman Sachs 12/17/20 JPMorgan VICI Properties initiated with an Overweight at JPMorgan GM General Motors $53.83 / -0.29 (-0.54%) 02/19/21 Morgan Stanley GM's 'hidden gems' drawing rising investor interest, says Morgan Stanley 02/18/21 Citi General Motors price target raised to $85 from $70 at Citi 02/16/21 Wedbush Wedbush expects Apple to announce formal EV partnership in 2021 02/11/21 RBC Capital General Motors price target raised to $67 from $52 at RBC Capital SSNLF Samsung $0.00 / + (+0.00%) 02/04/21 Craig-Hallum Qorvo price target raised to $195 from $160 at Craig-Hallum 02/04/21 Craig-Hallum Digital Turbine price target raised to $80 from $60 at Craig-Hallum 01/29/21 Needham Skyworks price target raised to $245 from $200 at Needham 01/26/21 Applied Materials upgraded to Buy at DA Davidson on semicap strength OVID Ovid Therapeutics $4.01 / +1.055 (+35.70%) 11:54 Today RBC Capital Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal 11:47 Today RBC Capital Ovid Therapeutics downgraded to Sector Perform from Outperform at RBC Capital 12/02/20 RBC Capital Ovid Therapeutics price target lowered to $5 from $17 at RBC Capital 12/02/20 Ladenburg Ovid Therapeutics price target lowered to $7 from $21 at Ladenburg TAK Takeda Pharmaceutical $17.55 / +0.3 (+1.74%) 11:54 Today RBC Capital Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal 01/29/21 Morgan Stanley Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham LYFT Lyft $62.05 / +4.99 (+8.75%) 02/11/21 KeyBanc Uber price target raised to $75 from $63 at KeyBanc 02/11/21 Needham Needham transfers coverage on Lyft, raises price target $70 from $50 02/10/21 DA Davidson Lyft price target raised to $66 from $58 at DA Davidson 02/10/21 Jefferies Lyft price target raised to $75 from $70 at Jefferies VIR Vir Biotechnology $39.75 / -18.05 (-31.23%) 11:37 Today H.C. Wainwright Vir Biotechnology selloff a 'terrific buying opportunity,' says H.C. Wainwright 02/25/21 Barclays Vir Biotechnology price target raised to $77 from $61 at Barclays 01/27/21 JPMorgan Vir Biotechnology added to analyst focus list as short idea at JPMorgan 01/27/21 H.C. Wainwright Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program WEN Wendy's $20.25 / -1.05 (-4.93%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank DLTR JWN MIK APO LVS VICI GM SSNLF OVID LYFT VIR WEN DLTR Dollar Tree $104.04 / +5 (+5.05%) 07:36 Today Dollar Tree reports Q4 EPS $2.13, consensus $2.11 11/24/20 Dollar Tree reports Q3 EPS $1.39, consensus $1.15 11/23/20 Notable companies reporting before tomorrow's open 11/23/20 Notable companies reporting before tomorrow's open JWN Nordstrom $35.58 / -1.87 (-4.99%) 03/02/21 Nordstrom sees FY21 revenue up more than 25%, consensus $13.46B 03/02/21 Nordstrom reports Q4 EPS 21c, consensus 14c 03/02/21 Nordstrom reports Q4 EPS 21c, consensus 14c 02/04/21 Nordstrom gives long-term outlook, sees sales growing low single-digits annually MIK Michaels $22.18 / +4.15 (+23.02%) 12/03/20 Michaels sees Q4 sales up in the mid-single digits, consensus $1.82B 12/03/20 Michaels reports Q3 adj. EPS 86c, consensus 59c 12/02/20 Notable companies reporting before tomorrow's open 12/02/20 Notable companies reporting before tomorrow's open APO Apollo Global $50.95 / +1.06 (+2.12%) 02/03/21 Apollo Global reports Q4 fee related EPS 63c, consensus 50c 02/02/21 Notable companies reporting before tomorrow's open 02/02/21 Notable companies reporting before tomorrow's open 10/29/20 Apollo Global reports Q3 fee-related EPS 63c, consensus 49c LVS Las Vegas Sands $66.12 / +1.18 (+1.82%) 01/27/21 Las Vegas Sands reports Q4 adjusted EPS (37c), consensus (32c) 01/27/21 Notable companies reporting after market close 10/21/20 Las Vegas Sands reports Q3 adjusted EPS (67c), consensus (59c) 10/21/20 Notable companies reporting after market close VICI VICI Properties $28.88 / +0.25 (+0.87%) 02/18/21 VICI Properties reports Q4 EPS 53c, consensus 48c 02/18/21 VICI Properties sees FY21 AFFO per share $1.82-$1.87, consensus $1.88 02/18/21 VICI Properties reports Q4 AFFO per share 46c, consensus 47c 10/28/20 VICI Properties reports Q3 adjusted FFO 43c, consensus 42c GM General Motors $53.83 / -0.29 (-0.54%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B SSNLF Samsung $0.00 / + (+0.00%) 01/27/21 Samsung sees overall profit weakening in Q1 01/27/21 Samsung reports Q4 operating profit KRW9.05T 01/07/21 Samsung sees Q4 operating profit KRW9.00T vs. KRW9.52T consensus 10/28/20 Samsung reports Q3 operating profit KRW12.35T vs KRW7.78T last year OVID Ovid Therapeutics $4.01 / +1.055 (+35.70%) 11/12/20 Ovid Therapeutics reports Q3 EPS (28c), consensus (36c) LYFT Lyft $62.05 / +4.99 (+8.75%) 02/09/21 Lyft reports Q4 revenue $569.9M, consensus $562.49M 02/09/21 Notable companies reporting after market close 12/02/20 Lyft sees Q4 sequential revenue growth at lower end of 11%-15% range 11/10/20 Lyft reports Q3 adj. EPS (89c), consensus (91c) VIR Vir Biotechnology $39.75 / -18.05 (-31.23%) 11/10/20 Vir Biotechnology reports Q3 EPS (67c), consensus (60c) WEN Wendy's $20.25 / -1.05 (-4.93%) 07:07 Today Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 04 Mar 25 Aug 08 Jul 17 Jun JWN MIK APO LVS GM SSNLF TAK LYFT JWN Nordstrom $35.58 / -1.87 (-4.99%) 01/02/21 Nordstrom looks like a department store survivor, Barron's says MIK Michaels $22.18 / +4.15 (+23.02%) 03/01/21 Michaels attracting buyout interest from private equity players, NY Times says 03/01/21 Apollo, another firm interested in acquiring Michaels, NY Times reports APO Apollo Global $50.95 / +1.06 (+2.12%) 03/01/21 Michaels attracting buyout interest from private equity players, NY Times says 03/01/21 Apollo, another firm interested in acquiring Michaels, NY Times reports 02/02/21 Apollo remains on UN watch list after Epstein report, FT says 01/20/21 Brookfield, KKR mull offers for $10B Aramco pipeline stake, Bloomberg says LVS Las Vegas Sands $66.12 / +1.18 (+1.82%) 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games GM General Motors $53.83 / -0.29 (-0.54%) 03/02/21 GM-backed Cruise in talks to acquire Voyage, Bloomberg reports 03/02/21 GM-backed Cruise in talks to acquire Voyage, Bloomberg reports 02/26/21 GM to furlough workers at Brazil plant for at least 20 days, Reuters reports 02/24/21 GM CFO believes worst of global chip shortage is over, CNBC reports SSNLF Samsung $0.00 / + (+0.00%) 06:19 Today Samsung eyes four sites in U.S. for new $17B chip plant, Reuters reports 02/17/21 Samsung, NXP, Infineon have power shut off in Austin, AAS reports 02/05/21 Samsung eyes Austin, Texas for new $17B chip plant, Reuters reports 01/27/21 Samsung reports Q4 operating profit 9.05T won, Bloomberg says TAK Takeda Pharmaceutical $17.55 / +0.3 (+1.74%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports LYFT Lyft $62.05 / +4.99 (+8.75%) 01/12/21 Uber, Lyft drivers and union sue over Prop. 22, Axios reports 11/24/20 Uber, Lyft awarded five-year contract by GSA worth up to $810M, Reuters reports 11/23/20 Key Biden technology adviser makes regulation seem more likely, Reuters says 11/07/20 Gig-work companies win in CA, still facing battles elsewhere, Barron's says DLTR JWN MIK APO LVS GM SSNLF OVID TAK LYFT VIR WEN DLTR Dollar Tree $104.04 / +5 (+5.05%) 08:57 Today Fly Intel: Pre-market Movers 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 11/24/20 Fly Intel: Wall Street's top stories for Tuesday 11/24/20 Fly Intel: Wall Street's top stories at midday JWN Nordstrom $35.58 / -1.87 (-4.99%) 03/02/21 Fly Intel: After-Hours Movers 01/14/21 Fly Intel: Pre-market Movers 01/13/21 Fly Intel: After-Hours Movers 12/31/20 Alphabet, Nordstrom target changes among today's top calls on Wall Street MIK Michaels $22.18 / +4.15 (+23.02%) 03/02/21 Fly Intel: Pre-market Movers 12/03/20 Fly Intel: Pre-market Movers 10/12/20 Fly Insider: Element Solutions, Sunrun among week's notable insider trades 09/04/20 Lululemon, Wayfair downgrades among today's top calls on Wall Street APO Apollo Global $50.95 / +1.06 (+2.12%) 03/02/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: Pre-market Movers LVS Las Vegas Sands $66.12 / +1.18 (+1.82%) 03/01/21 Macau GGR spikes over 135% in February vs. last year 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting GM General Motors $53.83 / -0.29 (-0.54%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday SSNLF Samsung $0.00 / + (+0.00%) 02/03/21 Fly Intel: What to watch in Qualcomm's earnings report 01/21/21 Fly Intel: What to watch in Intel's earnings report 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 OVID Ovid Therapeutics $4.01 / +1.055 (+35.70%) 08:57 Today Fly Intel: Pre-market Movers 12/02/20 Fly Intel: Wall Street's top stories for Wednesday 12/02/20 Fly Intel: Wall Street's top stories at midday 12/01/20 Fly Intel: After-Hours Movers TAK Takeda Pharmaceutical $17.55 / +0.3 (+1.74%) 08:57 Today Fly Intel: Pre-market Movers LYFT Lyft $62.05 / +4.99 (+8.75%) 03/02/21 Fly Intel: After-Hours Movers 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers VIR Vir Biotechnology $39.75 / -18.05 (-31.23%) 02/17/21 Fly Intel: Pre-market Movers 01/27/21 Fly Intel: Wall Street's top stories for Wednesday 01/27/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: Wall Street's top stories for Tuesday WEN Wendy's $20.25 / -1.05 (-4.93%) 08:57 Today Fly Intel: Pre-market Movers 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 03/02/21 41st Annual Healthcare Virtual Conference 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 08:30 Today Wendy's - WEN 08:30 Today Ovid Therapeutics - OVID 09:00 Today Dollar Tree - DLTR 03/04/21 Michaels - MIK 03/05/21 General Motors - GM 03/16/21 Wendy's DLTR JWN MIK APO LVS GM OVID TAK LYFT DLTR Dollar Tree $104.04 / +5 (+5.05%) 12/16/20 Early notable gainers among liquid option names on December 16th 11/24/20 Early notable gainers among liquid option names on November 24th 10/23/20 Dollar Tree call volume above normal and directionally bullish JWN Nordstrom $35.58 / -1.87 (-4.99%) 03/02/21 Nordstrom options imply 13.1% move in share price post-earnings 01/29/21 Nordstrom put buyer realizes 156% same-day gains 01/25/21 Early notable gainers among liquid option names on January 25th 12/31/20 Early notable gainers among liquid option names on December 31st MIK Michaels $22.18 / +4.15 (+23.02%) 01/27/21 Unusually active option classes on open January 27th APO Apollo Global $50.95 / +1.06 (+2.12%) 10/22/20 Apollo Global put volume heavy and directionally bearish LVS Las Vegas Sands $66.12 / +1.18 (+1.82%) 02/11/21 Las Vegas Sands put volume heavy and directionally bearish 02/05/21 Early notable gainers among liquid option names on February 5th 01/27/21 Las Vegas Sands call volume above normal and directionally bullish 11/02/20 Unusually active option classes on open November 2nd GM General Motors $53.83 / -0.29 (-0.54%) 08:55 Today Notable open interest changes for March 3rd 03/02/21 General Motors call volume above normal and directionally bullish 01/28/21 General Motors call volume above normal and directionally bullish 01/20/21 Notable open interest changes for January 20th OVID Ovid Therapeutics $4.01 / +1.055 (+35.70%) 09:40 Today Unusually active option classes on open March 3rd TAK Takeda Pharmaceutical $17.55 / +0.3 (+1.74%) 01/22/21 Takeda Pharmaceutical call volume above normal and directionally bullish LYFT Lyft $62.05 / +4.99 (+8.75%) 02/25/21 Lyft call volume above normal and directionally bullish 02/11/21 Unusually active option classes on open February 11th 02/09/21 Lyft options imply 13.2% move in share price post-earnings 01/19/21 Lyft call volume above normal and directionally bullish
Periodicals	Aston Martin rolls out new Formula One car, CNBC reports » 12:22 03/03/21 03/03 12:22 03/03/21 12:22 ARGGY Aston Martin Lagonda $0.00 / + (+0.00%) Aston Martin is rolling… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ARGGY Aston Martin Lagonda $0.00 / + (+0.00%) 12:03 Today Bombardier, Aston Martin sign LOI for custom design services on business jets 10/27/20 Mercedes-Benz to increase stake in Aston Martin as part of expanded partnership 10/27/20 Mercedes-Benz to increase Aston Martin stake up to 20% ARGGY Aston Martin Lagonda $0.00 / + (+0.00%) 11/24/20 Deutsche Bank Aston Martin Lagonda price target raised to 70 GBp from 45 GBp at Deutsche Bank 09/08/20 Bernstein Aston Martin Lagonda initiated with an Outperform at Bernstein 08/04/20 Deutsche Bank Aston Martin Lagonda price target raised to 45 GBp from 35 GBp at Deutsche Bank 06/05/20 JPMorgan JPMorgan backs Neutral on Aston Martin Lagonda after cost structure announcement ARGGY Aston Martin Lagonda $0.00 / + (+0.00%) 10/27/20 Aston Martin Lagonda targets GBP 2B in revenue by fiscal 2024-2025
Hot Stocks	Micron sees FY cash flow better vs. last year 12:19 03/03/21 03/03 12:19 03/03/21 12:19 MU Micron $91.56 / +0.52 (+0.57%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $91.56 / +0.52 (+0.57%) 12:19 Today Micron sees cash flow better in back half of the year 12:13 Today Micron CFO says NAND capacity increases cause uncertainty 12:10 Today Micron CFO sees DRAM supply tight for the rest of the year 12:01 Today Micron CFO says company can be 'very selective' with M&A MU Micron $91.56 / +0.52 (+0.57%) 10:25 Today Raymond James Micron management expected to maintain bullish view on DRAM, says Raymond James 08:24 Today Lynx Micron 'has become a crowded long,' says Lynx 06:42 Today Citi Citi boosts Micron target to $116, still sees $150 stock longer term 03/02/21 Evercore ISI Micron price target raised to $135 from $105 at Evercore ISI MU Micron $91.56 / +0.52 (+0.57%) 09:17 Today Micron raises Q2 adjusted EPS view 93c-98c from 68c-82c, consensus 79c 01/07/21 Micron sees Q2 EPS 75c +/- 7c, consensus 63c 01/07/21 Micron reports Q1 EPS 78c, consensus 71c 01/07/21 Notable companies reporting after market close MU Micron $91.56 / +0.52 (+0.57%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/11/21 Biden administration called on by chip industry to fund factories, Reuters says 12/04/20 Micron fab power outage may impact global DRAM supply, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports MU Micron $91.56 / +0.52 (+0.57%) 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Technology, Media & Telecom Virtual Conference 03/31/21 Micron - MU MU Micron $91.56 / +0.52 (+0.57%) 02/26/21 Micron call volume above normal and directionally bullish 01/20/21 Micron call buyer realizes 56% same-day gains 01/07/21 Micron options imply 9.7% move in share price post-earnings 01/05/21 Micron call volume above normal and directionally bullish

Hot Stocks	Micron sees cash flow better in back half of the year 12:19 03/03/21 03/03 12:19 03/03/21 12:19 MU Micron $91.56 / +0.52 (+0.57%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $91.56 / +0.52 (+0.57%) 12:13 Today Micron CFO says NAND capacity increases cause uncertainty 12:10 Today Micron CFO sees DRAM supply tight for the rest of the year 12:01 Today Micron CFO says company can be 'very selective' with M&A 11:51 Today Micron CFO seeing strength in mobile, cloud, graphics, automotive MU Micron $91.56 / +0.52 (+0.57%) 10:25 Today Raymond James Micron management expected to maintain bullish view on DRAM, says Raymond James 08:24 Today Lynx Micron 'has become a crowded long,' says Lynx 06:42 Today Citi Citi boosts Micron target to $116, still sees $150 stock longer term 03/02/21 Evercore ISI Micron price target raised to $135 from $105 at Evercore ISI MU Micron $91.56 / +0.52 (+0.57%) 09:17 Today Micron raises Q2 adjusted EPS view 93c-98c from 68c-82c, consensus 79c 01/07/21 Micron sees Q2 EPS 75c +/- 7c, consensus 63c 01/07/21 Micron reports Q1 EPS 78c, consensus 71c 01/07/21 Notable companies reporting after market close MU Micron $91.56 / +0.52 (+0.57%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/11/21 Biden administration called on by chip industry to fund factories, Reuters says 12/04/20 Micron fab power outage may impact global DRAM supply, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports MU Micron $91.56 / +0.52 (+0.57%) 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Technology, Media & Telecom Virtual Conference 03/31/21 Micron - MU MU Micron $91.56 / +0.52 (+0.57%) 02/26/21 Micron call volume above normal and directionally bullish 01/20/21 Micron call buyer realizes 56% same-day gains 01/07/21 Micron options imply 9.7% move in share price post-earnings 01/05/21 Micron call volume above normal and directionally bullish
Hot Stocks	FedEx invests more $2B to become carbon-neutral by 2040 » 12:19 03/03/21 03/03 12:19 03/03/21 12:19 FDX FedEx $261.50 / +1.955 (+0.75%) FedEx announced a goal to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FDX FedEx $261.50 / +1.955 (+0.75%) 03/01/21 FedEx begins shipping newly approved Covid vaccine on behalf of McKesson 01/26/21 FedEx Ground CEO Maier to retire July 31, John Smith to succeed 01/19/21 FedEx Express plans to cut 5,500-6,300 jobs in Europe 12/20/20 Fly Intel: Top five weekend stock stories FDX FedEx $261.50 / +1.955 (+0.75%) 01/07/21 Wolfe Research FedEx downgraded to Peer Perform from Outperform at Wolfe Research 12/30/20 Argus FedEx price target raised to $305 from $270 at Argus 12/18/20 Raymond James FedEx price target raised to $305 from $280 at Raymond James 12/18/20 Morgan Stanley FedEx's 'modest' Q2 beat likely falls short of high bar, says Morgan Stanley FDX FedEx $261.50 / +1.955 (+0.75%) 12/17/20 FedEx aims to increase EPS by 10%-15 per year over long term 12/17/20 FedEx reports Q2 EPS $4.83, consensus $4.01 12/17/20 Notable companies reporting after market close 09/15/20 FedEx reports Q1 adjusted EPS $4.87, consensus $2.69 FDX FedEx $261.50 / +1.955 (+0.75%) 03/02/21 Johnson & Johnson Covid-19 vaccine shipments begin rollout, WSJ reports 12/15/20 FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports 11/25/20 FedEx, UPS run into shortage of vans amid delivery rush, Bloomberg reports 11/10/20 Amazon moving into middle-mile trucking business, The Information reports FDX FedEx $261.50 / +1.955 (+0.75%) 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 12/18/20 Fly Intel: Pre-market Movers 03/18/21 FedEx - FDX FDX FedEx $261.50 / +1.955 (+0.75%) 02/05/21 Unusually active option classes on open February 5th 12/17/20 Fedex options imply 9.8% move in share price post-earnings 09/24/20 Unusual call flow in option market yesterday 09/23/20 Fedex puts deliver express profits as shares tumble $6
Technical Analysis	NASDAQ market internals summary » 12:17 03/03/21 03/03 12:17 03/03/21 12:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/02/21 NASDAQ market internals summary 03/02/21 NASDAQ market internals summary
Syndicate	Oscar Health opens at $36, IPO priced at $39 per share 12:16 03/03/21 03/03 12:16 03/03/21 12:16 OSCR Oscar Health $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate On The Fly 03 Mar OSCR Oscar Health $0.00 / + (+0.00%) 02/28/21 Opening Day: Coinbase files to go public
Technical Analysis	NYSE market internals summary » 12:16 03/03/21 03/03 12:16 03/03/21 12:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 03/02/21 NYSE market internals summary 03/02/21 NYSE market internals summary

Options	Bausch Health put volume heavy and directionally bearish » 12:15 03/03/21 03/03 12:15 03/03/21 12:15 BHC Bausch Health $32.34 / +0.06 (+0.19%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BHC Bausch Health $32.34 / +0.06 (+0.19%) 02/26/21 Bausch Health to reduce debt by $100M 02/24/21 Bausch Health adds Brett Icahn, Steven Miller to board as independent directors 02/23/21 Bausch + Lomb launches Alaway Preservative Free antihistamine eye drops 02/22/21 Bausch Health to reduce debt by $100M using cash generated from operations BHC Bausch Health $32.34 / +0.06 (+0.19%) 03/02/21 Citi Bausch Health price target raised to $37 from $32 at Citi 02/25/21 Barclays Bausch Health price target raised to $35 from $27 at Barclays 02/17/21 RBC Capital Bausch Health upgraded to Outperform from Sector Perform at RBC Capital 02/17/21 RBC Capital Bausch Health upgraded to Outperform from Sector Perform at RBC Capital BHC Bausch Health $32.34 / +0.06 (+0.19%) 02/24/21 Bausch Health sees FY21 revenue $8.6B-$8.8B, consensus $8.5B 02/24/21 Bausch Health reports Q4 revenue $2.21B, consensus $2.17B 01/12/21 Bausch Health sees Q4 revenue over $2.20B, consensus $2.12B 11/03/20 Bausch Health reports Q3 adjusted EBITDA $948M, consensus $844.9M BHC Bausch Health $32.34 / +0.06 (+0.19%) 12/29/20 Fly Intel: Pre-market Movers 11/03/20 Fly Intel: Pre-market Movers 10/08/20 Fly Intel: Pre-market Movers 03/02/21 Global High Yield & Leveraged Finance Virtual Conference BHC Bausch Health $32.34 / +0.06 (+0.19%) 01/05/21 Bausch Health call volume above normal and directionally bullish 01/04/21 Bausch Health call volume above normal and directionally bullish 12/31/20 Largest borrow rate increases among liquid names 12/29/20 Bausch Health call volume above normal and directionally bullish
Hot Stocks	Micron CFO says NAND capacity increases cause uncertainty 12:13 03/03/21 03/03 12:13 03/03/21 12:13 MU Micron $92.42 / +1.38 (+1.52%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $92.42 / +1.38 (+1.52%) 12:10 Today Micron CFO sees DRAM supply tight for the rest of the year 12:01 Today Micron CFO says company can be 'very selective' with M&A 11:51 Today Micron CFO seeing strength in mobile, cloud, graphics, automotive 11:49 Today Micron CFO: 'Things really tight,' particularly in DRAM MU Micron $92.42 / +1.38 (+1.52%) 10:25 Today Raymond James Micron management expected to maintain bullish view on DRAM, says Raymond James 08:24 Today Lynx Micron 'has become a crowded long,' says Lynx 06:42 Today Citi Citi boosts Micron target to $116, still sees $150 stock longer term 03/02/21 Evercore ISI Micron price target raised to $135 from $105 at Evercore ISI MU Micron $92.42 / +1.38 (+1.52%) 09:17 Today Micron raises Q2 adjusted EPS view 93c-98c from 68c-82c, consensus 79c 01/07/21 Micron sees Q2 EPS 75c +/- 7c, consensus 63c 01/07/21 Micron reports Q1 EPS 78c, consensus 71c 01/07/21 Notable companies reporting after market close MU Micron $92.42 / +1.38 (+1.52%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/11/21 Biden administration called on by chip industry to fund factories, Reuters says 12/04/20 Micron fab power outage may impact global DRAM supply, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports MU Micron $92.42 / +1.38 (+1.52%) 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Technology, Media & Telecom Virtual Conference 03/31/21 Micron - MU MU Micron $92.42 / +1.38 (+1.52%) 02/26/21 Micron call volume above normal and directionally bullish 01/20/21 Micron call buyer realizes 56% same-day gains 01/07/21 Micron options imply 9.7% move in share price post-earnings 01/05/21 Micron call volume above normal and directionally bullish
Hot Stocks	Lucid Motors teases in-vehicle entertainment partnership with Dolby » 12:12 03/03/21 03/03 12:12 03/03/21 12:12 CCIV Churchill Capital Corp IV $26.03 / -1.68 (-6.06%) , DLB Dolby $99.84 / -0.28 (-0.28%) In a tweet, Lucid Motors… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CCIV CCIV Churchill Capital Corp IV $26.03 / -1.68 (-6.06%) 02/23/21 Churchill Capital Corp IV falls -31.9% 02/23/21 Churchill Capital Corp IV falls -43.9% 02/23/21 Churchill Capital Corp IV falls -44.0% 02/23/21 Churchill Capital sinks 37% after reaching anticipated merger Lucid Motor CCIV DLB CCIV Churchill Capital Corp IV $26.03 / -1.68 (-6.06%) 02/23/21 Wells Fargo Trinity Capital initiated with an Overweight at Wells Fargo DLB Dolby $99.84 / -0.28 (-0.28%) 01/29/21 B. Riley Securities Dolby price target raised to $89 from $79 at B. Riley Securities 01/04/21 Barrington Dolby downgraded to Market Perform on valuation at Barrington 01/04/21 Barrington Dolby downgraded to Market Perform from Outperform at Barrington 11/13/20 B. Riley Securities Dolby price target raised to $79 from $73 at B. Riley Securities DLB DLB Dolby $99.84 / -0.28 (-0.28%) 01/28/21 Dolby sees Q2 adjusted EPS 57c-72c, consensus 62c 01/28/21 Dolby reports Q1 adjusted EPS $1.48, consensus $1.04 11/12/20 Dolby sees Q2 revenue $270M-$300M 11/12/20 Dolby sees Q1 adjusted EPS 97c-$1.12, consensus 56c CCIV CCIV Churchill Capital Corp IV $26.03 / -1.68 (-6.06%) 02/26/21 Portnoy says he bought Churchill Capital IV shares, will 'probably get killed' 02/23/21 Lucid CEO tells Bloomberg production delay due to Churchill concerns 02/21/21 Lucid Motors said to be near deal to go public via SPAC, Bloomberg reports 02/16/21 Churchill Capital soars after Reuters says deal with Lucid Motors is close CCIV DLB CCIV Churchill Capital Corp IV $26.03 / -1.68 (-6.06%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 SPACs slide after Lucid Motors confirms anticipated come-public deal DLB Dolby $99.84 / -0.28 (-0.28%) 01/28/21 Fly Intel: After-Hours Movers 11/12/20 Fly Intel: After-Hours Movers CCIV CCIV Churchill Capital Corp IV $26.03 / -1.68 (-6.06%) 02/26/21 Unusually active option classes on open February 26th 02/16/21 Unusually active option classes on open February 16th 02/03/21 Largest borrow rate increases among liquid names 02/03/21 Churchill Capital Corp IV call buyer realizes 77% same-day gains
Hot Stocks	Micron CFO sees DRAM supply tight for the rest of the year 12:10 03/03/21 03/03 12:10 03/03/21 12:10 MU Micron $92.82 / +1.78 (+1.96%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $92.82 / +1.78 (+1.96%) 12:01 Today Micron CFO says company can be 'very selective' with M&A 11:51 Today Micron CFO seeing strength in mobile, cloud, graphics, automotive 11:49 Today Micron CFO: 'Things really tight,' particularly in DRAM 11:48 Today Micron: NAND volume running more positively than expected MU Micron $92.82 / +1.78 (+1.96%) 10:25 Today Raymond James Micron management expected to maintain bullish view on DRAM, says Raymond James 08:24 Today Lynx Micron 'has become a crowded long,' says Lynx 06:42 Today Citi Citi boosts Micron target to $116, still sees $150 stock longer term 03/02/21 Evercore ISI Micron price target raised to $135 from $105 at Evercore ISI MU Micron $92.82 / +1.78 (+1.96%) 09:17 Today Micron raises Q2 adjusted EPS view 93c-98c from 68c-82c, consensus 79c 01/07/21 Micron sees Q2 EPS 75c +/- 7c, consensus 63c 01/07/21 Micron reports Q1 EPS 78c, consensus 71c 01/07/21 Notable companies reporting after market close MU Micron $92.82 / +1.78 (+1.96%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/11/21 Biden administration called on by chip industry to fund factories, Reuters says 12/04/20 Micron fab power outage may impact global DRAM supply, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports MU Micron $92.82 / +1.78 (+1.96%) 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Technology, Media & Telecom Virtual Conference 03/31/21 Micron - MU MU Micron $92.82 / +1.78 (+1.96%) 02/26/21 Micron call volume above normal and directionally bullish 01/20/21 Micron call buyer realizes 56% same-day gains 01/07/21 Micron options imply 9.7% move in share price post-earnings 01/05/21 Micron call volume above normal and directionally bullish
Recommendations	Ocugen price target raised to $15 from $4 at Cantor Fitzgerald » 12:08 03/03/21 03/03 12:08 03/03/21 12:08 OCGN Ocugen $11.83 / +2.24 (+23.36%) Cantor Fitzgerald analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options OCGN Ocugen $11.83 / +2.24 (+23.36%) 08:20 Today Ocugen, Bharat Biotech announce Phase 3 interim results of COVAXIN 02/23/21 Ocugen granted orphan medicinal product designation for OCU400 by EMA 02/08/21 Ocugen Inc trading resumes 02/08/21 Ocugen Inc trading halted, volatility trading pause OCGN Ocugen $11.83 / +2.24 (+23.36%) 02/09/21 Fly Intel: Top five analyst downgrades 02/09/21 Chardan Chardan raises Ocugen target to $13, downgrades to Neutral after rally 02/09/21 Chardan Ocugen downgraded to Neutral from Buy at Chardan 02/08/21 Cantor Fitzgerald Cantor says Ocugen starting to receive more attention for COVID-19 vaccine OCGN Ocugen $11.83 / +2.24 (+23.36%) 11/06/20 Ocugen reports Q3 EPS (7c), consensus (2c) OCGN Ocugen $11.83 / +2.24 (+23.36%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Ocugen soars after offering as analyst sees more vaccine, social media attention 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/16/21 Ocugen Inc OCGN Ocugen $11.83 / +2.24 (+23.36%) 09:40 Today Unusually active option classes on open March 3rd 02/18/21 Fourteen new option listings and one option delisting on February 18th

Options	TripAdvisor call volume above normal and directionally bullish » 12:05 03/03/21 03/03 12:05 03/03/21 12:05 TRIP TripAdvisor $53.17 / +0.47 (+0.89%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TRIP TripAdvisor $53.17 / +0.47 (+0.89%) 02/18/21 TripAdvisor sees Q1 revenue, adjusted EBITDA roughly in line with 4Q20 02/18/21 TripAdvisor: January revenue performance dipped slightly relative to December 02/18/21 TripAdvisor entering 2021 'with optimism' 02/18/21 TripAdvisor CEO says 'pent up travel demand continues to grow' TRIP TripAdvisor $53.17 / +0.47 (+0.89%) 03/02/21 Citi TripAdvisor upgraded to Buy from Neutral at Citi 02/23/21 Wells Fargo TripAdvisor price target raised to $47 from $32 at Wells Fargo 02/22/21 DA Davidson TripAdvisor price target raised to $46 from $26 at DA Davidson 02/22/21 Stifel TripAdvisor price target raised to $39 from $26 at Stifel TRIP TripAdvisor $53.17 / +0.47 (+0.89%) 02/18/21 TripAdvisor reports Q4 adjusted EPS (41c), consensus (25c) 02/18/21 Notable companies reporting after market close 11/06/20 TripAdvisor expects Q4 revenue to be modestly lower than Q3, consensus $174.93M 11/05/20 TripAdvisor reports Q3 adjusted EPS (17c), consensus (26c) TRIP TripAdvisor $53.17 / +0.47 (+0.89%) 10/23/20 TripAdvisor CEO welcomes DOJ move to look into Google, CNBC reports 09/29/20 Amazon gets into virtual tourism, with Amazon Explore, GeekWire reports TRIP TripAdvisor $53.17 / +0.47 (+0.89%) 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 01/08/21 Another Tesla upgrade among today's top calls on Wall Street 12/02/20 Fly Intel: Pre-market Movers 12/01/20 Pinterest, FedEx upgrades among today's top calls on Wall Street 03/02/21 Technology, Media & Telecom Virtual Conference TRIP TripAdvisor $53.17 / +0.47 (+0.89%) 02/26/21 TripAdvisor call volume above normal and directionally bullish 02/25/21 TripAdvisor call volume above normal and directionally bullish 02/24/21 TripAdvisor call volume above normal and directionally bullish 01/08/21 Early notable gainers among liquid option names on January 8th
Recommendations	Caladrius price target raised to $10 from $7 at Brookline » 12:04 03/03/21 03/03 12:04 03/03/21 12:04 CLBS Caladrius $1.85 / -0.02 (-1.07%) Brookline analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options CLBS Caladrius $1.85 / -0.02 (-1.07%) 01/19/21 Caladrius initiates Phase 2b trial of CLBS16 in coronary disfunction 12/14/20 Caladrius expects available capital fo fund company through 2021 12/14/20 Caladrius suspends execution of current pilot study of CLBS119 12/14/20 Caladrius provides year-end 2020 strategic portfolio update CLBS Caladrius $1.85 / -0.02 (-1.07%) 01/19/21 H.C. Wainwright Caladrius price target lowered to $14 from $18.50 at H.C. Wainwright 05/22/20 Brookline Caladrius initiated with a Buy at Brookline 05/18/20 Dawson James Caladrius downgraded to Neutral from Buy at Dawson James CLBS Caladrius $1.85 / -0.02 (-1.07%) 11/05/20 Caladrius reports Q3 EPS (29c), consensus (29c) CLBS Caladrius $1.85 / -0.02 (-1.07%) 02/02/21 Largest borrow rate increases among liquid names
Recommendations	Golden Entertainment shares worth $40 based on Sands deal, says Roth Capital » 12:03 03/03/21 03/03 12:03 03/03/21 12:03 GDEN Golden Entertainment $24.99 / +0.97 (+4.04%) , LVS Las Vegas Sands $66.42 / +1.48 (+2.28%) , CZR Caesars $96.53 / +3.58 (+3.85%) Las Vegas Sands'… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options LVS CZR LVS Las Vegas Sands $66.42 / +1.48 (+2.28%) 06:38 Today VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B 06:34 Today Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B 06:34 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B 03/01/21 Macau reports February casino revenue up 135.6% to 7.31B patacas CZR Caesars $96.53 / +3.58 (+3.85%) 02/25/21 Caesars says expect to close William Hill deal past U.K. court date on 3/30 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/23/21 Texas proposes constitutional amendment to legalize sports wagering GDEN LVS CZR GDEN Golden Entertainment $24.99 / +0.97 (+4.04%) 12/02/20 Macquarie Golden Entertainment price target raised to $26 from $24 at Macquarie 11/06/20 Deutsche Bank Golden Entertainment price target raised to $20 from $15 at Deutsche Bank 11/02/20 Roth Capital Golden Entertainment initiated with a Buy at Roth Capital 10/26/20 Deutsche Bank Golden Entertainment contingent payment a potential catalyst, says Deutsche Bank LVS Las Vegas Sands $66.42 / +1.48 (+2.28%) 10:02 Today Stifel Las Vegas Sands casino sale news 'clearly a positive,' says Stifel 02/09/21 Morgan Stanley Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds 02/08/21 Fly Intel: Top five analyst downgrades 02/08/21 BofA Las Vegas Sands downgraded to Neutral from Buy at BofA CZR Caesars $96.53 / +3.58 (+3.85%) 03/01/21 KeyBanc Caesars price target raised to $102 from $89 at KeyBanc 02/26/21 Macquarie Caesars price target raised to $100 from $86 at Macquarie 02/26/21 Loop Capital Caesars price target raised to $92 from $82 at Loop Capital 02/26/21 Cowen Caesars price target raised to $90 from $82 at Cowen GDEN LVS CZR GDEN Golden Entertainment $24.99 / +0.97 (+4.04%) 11/05/20 Golden Entertainment reports Q3 EPS (25c), consensus (85c) LVS Las Vegas Sands $66.42 / +1.48 (+2.28%) 01/27/21 Las Vegas Sands reports Q4 adjusted EPS (37c), consensus (32c) 01/27/21 Notable companies reporting after market close 10/21/20 Las Vegas Sands reports Q3 adjusted EPS (67c), consensus (59c) 10/21/20 Notable companies reporting after market close CZR Caesars $96.53 / +3.58 (+3.85%) 02/25/21 Caesars reports Q4 EPS ($1.91), consensus ($1.76) 02/25/21 Notable companies reporting after market close 11/05/20 Caesars reports Q3 EPS ($6.09), consensus ($2.15) 11/05/20 Notable companies reporting after market close 29 Sep LVS CZR LVS Las Vegas Sands $66.42 / +1.48 (+2.28%) 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games CZR Caesars $96.53 / +3.58 (+3.85%) 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games LVS CZR LVS Las Vegas Sands $66.42 / +1.48 (+2.28%) 03/01/21 Macau GGR spikes over 135% in February vs. last year 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting CZR Caesars $96.53 / +3.58 (+3.85%) 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/25/21 Fly Intel: After-Hours Movers 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 03/11/21 Golden Entertainment - GDEN LVS CZR LVS Las Vegas Sands $66.42 / +1.48 (+2.28%) 02/11/21 Las Vegas Sands put volume heavy and directionally bearish 02/05/21 Early notable gainers among liquid option names on February 5th 01/27/21 Las Vegas Sands call volume above normal and directionally bullish 11/02/20 Unusually active option classes on open November 2nd CZR Caesars $96.53 / +3.58 (+3.85%) 11/24/20 Caesars call volume above normal and directionally bullish 09/08/20 Caesars put volume heavy and directionally bearish 09/03/20 Caesars call volume above normal and directionally bullish
Hot Stocks	Bombardier, Aston Martin sign LOI for custom design services on business jets » 12:03 03/03/21 03/03 12:03 03/03/21 12:03 BDRBF Bombardier $0.00 / + (+0.00%) , ARGGY Aston Martin Lagonda $0.00 / + (+0.00%) Aston Martin (ARGGY) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BDRBF ARGGY BDRBF Bombardier $0.00 / + (+0.00%) 02/23/21 Bombardier reports suffering 'limited cybersecurity breach' 02/17/21 Bombardier announces repayment of senior secured credit facility 02/11/21 Bombardier launches actions to improve profitability and cash generation 02/11/21 Bombardier says Learjet production to end in 4Q21 ARGGY Aston Martin Lagonda $0.00 / + (+0.00%) 10/27/20 Mercedes-Benz to increase stake in Aston Martin as part of expanded partnership 10/27/20 Mercedes-Benz to increase Aston Martin stake up to 20% BDRBF ARGGY BDRBF Bombardier $0.00 / + (+0.00%) 02/16/21 Cowen Bombardier downgraded to Underperform from Market Perform at Cowen 02/16/21 Scotiabank Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank 02/12/21 National Bank Bombardier price target lowered to C$0.70 from C$0.80 at National Bank 02/12/21 BMO Capital Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital ARGGY Aston Martin Lagonda $0.00 / + (+0.00%) 11/24/20 Deutsche Bank Aston Martin Lagonda price target raised to 70 GBp from 45 GBp at Deutsche Bank 09/08/20 Bernstein Aston Martin Lagonda initiated with an Outperform at Bernstein 08/04/20 Deutsche Bank Aston Martin Lagonda price target raised to 45 GBp from 35 GBp at Deutsche Bank 06/05/20 JPMorgan JPMorgan backs Neutral on Aston Martin Lagonda after cost structure announcement BDRBF ARGGY BDRBF Bombardier $0.00 / + (+0.00%) 02/11/21 Bombardier reports Q4 cont ops EPS (1c), consensus 0c 02/11/21 Bombardier sees FY21 adjusted EBITDA greater than $500M ARGGY Aston Martin Lagonda $0.00 / + (+0.00%) 10/27/20 Aston Martin Lagonda targets GBP 2B in revenue by fiscal 2024-2025 BDRBF BDRBF Bombardier $0.00 / + (+0.00%) 11/13/20 Disney upgrade among today's top calls on Wall Street 05/06/21 Bombardier - BDRBF
Hot Stocks	Tian Ruixiang Holdings Ltd (Class A Stock) trading resumes 12:03 03/03/21 03/03 12:03 03/03/21 12:03 TIRX Tian Ruixiang $92.51 / +0.36 (+0.39%) ShowHide Related Items >><< Company News Syndicate On The Fly TIRX Tian Ruixiang $92.51 / +0.36 (+0.39%) 11:58 Today Tian Ruixiang Holdings Ltd (Class A Stock) trading halted, volatility trading pause 27 Jan TIRX Tian Ruixiang $92.51 / +0.36 (+0.39%) 01/31/21 Opening Day: Qualtrics jumps 40% in trading debut

Events

Earnings calls, analyst events, roadshows and more

FICO
Today at 12:30

Fair Isaac Corp. (FICO) Firm Sponsored Meetings

181 Metro Dr, San Jose, CA
Today at 13:00

Fed Reserve Bank President Speaks on Economic Conditions Government Event

Virtual Event
VLDR
Today at 13:00

Velodyne Lidar Firm Sponsored Meetings

Virtual Meeting
ADBE
Today at 13:00

Software & Internet Industry Meetings
FLWS
Today at 14:00

1-800-Flowers.com - FLWS Conference Calls
NGVC
Today at 15:00

Natural Grocers by Vitamin Cottage, Inc. Firm Sponsored Meetings
IVZ
Today at 16:15

Real Estate Investing After COVID-19 Government Event

Virtual Event
SPLK
Today at 16:30

Splunk - SPLK Conference Calls
AEO
Today at 16:30

American Eagle - AEO Conference Calls
PCOM
Today at 16:30

Points International - PCOM Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank $28.48 60M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

Society for Immunotherapy of Cancer to hold virtual annual meeting

TODAY'S FREE FLY STORIES

Get Full Fly Access